Published January 7, 2026 | Version 1
Technical note Open

Comparing the quantitation of specialized pro-resolving mediators in plasma and serum using ELISA and LC-MS/MS.

Authors/Creators

  • 1. ROR icon Cardiff University
  • 2. ROR icon Cayman Chemical (United States)
  • 3. EDMO icon University of Pennsylvania
  • 4. ROR icon University of Colorado Health

Contributors

  • 1. ROR icon Cardiff University

Description

Quantitation of oxylipins is generally performed using liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). Researchers can also use commercial enzyme-linked immunosorbent assays (ELISAs), due to convenience or where access to instrumentation is limited. However, oxylipins are small molecules with many isomers and metabolites that are difficult to fully discriminate using ELISAs, with many potential sources of cross-reactivity. In this paper, the use of ELISAs for oxylipin analysis is compared with LC-MS/MS, with two specialized pro-resolving mediators (SPM) as examples. By reviewing the literature, we show that ELISAs report significantly higher levels of resolvin D1 (RvD1) and resolvin D2 (RvD2) than LC-MS/MS. Also, we show experimentally that in plasma and serum samples where these lipids were not detected using LC-MS/MS, a positive result could be obtained using ELISA, and that these signals increase with improper sample processing. In conclusion, while ELISA can be a valuable screening tool for the presence of oxylipins, positive signals need validation using LC-MS/MS.

Files

ELISA paper_draft final.pdf

Files (763.3 kB)

Name Size Download all
md5:eb8dbf76ad65360fd779539260af6ae7
763.3 kB Preview Download

Additional details

Funding

UK Research and Innovation
MAP/UK MR/S010483/1